PPARG and inflammatory bowel disease: Although our findings suggest that the reparative impact of ABA relies on PPARγ activation, it was previously reported that ABA does not bind to the ligand-binding-domain of PPARγ (61) and expression of PPARγ in intestinal epithelial cells was not required for the anti-inflammatory efficacy of ABA in inflammatory bowel disease (88).